Abbott Laboratories (NYSE:ABT) reported its Q1 earnings results on Wednesday, April 20, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Abbott Laboratories beat estimated earnings by 17.69%, reporting an EPS of $1.73 versus an estimate of $1.47.
Revenue was up $1.44 billion from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 0.31% increase in the share price the next day.
Here's a look at Abbott Laboratories's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 1.21 | 0.94 | 1.02 | 1.27 |
| EPS Actual | 1.32 | 1.40 | 1.17 | 1.32 |
| Revenue Estimate | 10.71B | 9.54B | 9.69B | 10.69B |
| Revenue Actual | 11.47B | 10.93B | 10.22B | 10.46B |
To track all earnings releases for Abbott Laboratories visit their earnings calendar here..
This article was generated by Benzinga's automated content engine and reviewed by an editor.
